MACKENZIE WENDT: Open Payments
NPI 1124802525 · JEANERETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $797 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $155 |
| Janssen Biotech, Inc. | 4 | $70 |
| PFIZER INC. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| GENZYME CORPORATION | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Ardelyx, Inc. | 2 | $35 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: RINVOQ, SKYRIZI, TREMFYA, XELJANZ, ENTYVIO, DUPIXENT, IQIRVO, IBSRELA.
Industry payments across LA — which companies pay providers there.
